MLYS: Mineralys Therapeutics Inc

15.05 USD 0.99 (7.04%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

MLYS exchange rate has changed by 7.04% for today. During the day, the instrument was traded at a low of 13.97 and at a high of 15.13.

Follow Mineralys Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

MLYS News

Zacks 16:00 Mineralys Therapeutics, Inc. (MLYS) Upgraded to Buy: Here's Why
Zacks 13:55 Does Mineralys Therapeutics, Inc. (MLYS) Have the Potential to Rally 154.21% as Wall Street Analysts Expect?
Investing 21:08 Mineralys Therapeutics CEO Congleton sells $230k in shares
Investing 21:06 Mineralys Therapeutics CFO Adam Levy sells $155k in stock
TipRanks 10:30 3 Best Stocks to Buy Now, 7/15/2025, According to Top Analysts - TipRanks.com
Investing 13:13 Jefferies maintains Hold rating on Mineralys stock amid AstraZeneca data
Investing 15:25 Mineralys reports positive phase 3 results for hypertension drug
Investing 11:31 Mineralys stock holds Buy rating at H.C. Wainwright after CKD trial
Benzinga 13:57 Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps - Mineralys Therapeutics (NASDAQ:MLYS)
Investing 12:35 Mineralys Therapeutics stock jumps after positive kidney disease trial data
Investing 11:05 Mineralys reports positive phase 2 data for lorundrostat in CKD
Seeking Alpha 14:10 PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
Benzinga 12:35 This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Core Natural Resources (NYSE:CNR), Coinbase Global (NASDAQ:COIN)
Investing 21:01 Jefferies initiates Mineralys Therapeutics stock with hold rating
Seeking Alpha 03:36 Akebia Therapeutics (AKBA): Stock At Fair Value Amid Robust Drug Adoption Into 2026
Seeking Alpha 15:51 Mineralys Therapeutics: Merits A Small 'Speculative' Holding (NASDAQ:MLYS)
Investing 10:13 Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension
Investing 12:05 Mineralys to present lorundrostat trial data at ESH 2025
Investing 00:04 Mineralys at BofA Securities 2025: Lorundrostat’s Hypertension Promise
TipRanks 09:35 3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts - TipRanks.com
TipRanks 09:53 3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts - TipRanks.com
Investing 18:40 Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual
Benzinga 12:36 Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Lazard (NYSE:LAZ), Amylyx Pharmaceuticals (NASDAQ:AMLX)
Seeking Alpha 22:25 Mineralys: Prospects Just Got Better With Successful Pivotal Data Readouts (NASDAQ:MLYS)

Daily Range

13.97 15.13

Year Range

8.24 18.99

Previous Close: 13.88
Open: 14.06

Bid: 15.05
Ask: 15.35

Low: 13.97
High: 15.13

Volume: 662

Daily Change: 7.04%
Month Change: 11.65%

6 Months Change: 46.12%
Year Change: 20.50%

30 July, Wednesday